Anti‐αLβ2 antibodies reveal novel endocytotic cross‐modulatory functionality
Sign Up to like & getrecommendations! Published in 2020 at "British Journal of Pharmacology"
DOI: 10.1111/bph.14996
Abstract: Antibodies targeting cell surface receptors are considered to enable highly selective therapeutic interventions for immune disorders and cancer. Their biological profiles are found, generally, to represent the net effects of antibody–target interactions. The former therapeutic… read more here.
Keywords: cross modulatory; novel endocytotic; antibodies reveal; reveal novel ... See more keywords